Digipath
Home > Boards > US Listed > Biotechs >

Nabriva Therapeutics AG (NBRV)

NBRV RSS Feed
Add NBRV Price Alert      Hide Sticky   Hide Intro
Moderator: bUrRpPPP!
Search This Board: 
Last Post: 1/15/2019 7:24:18 AM - Followers: 12 - Board type: Free - Posts Today: 0

Nabriva Therapeutics AG Leberstrasse 20 Vienna, 1110 Austria Phone: 43 1 740 93 0 Fax: 43 1 740 93 1900 Website: http://www.nabriva.com Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It is also developing BC-7013, a topical pleuromutilin product candidate, which has completed a Phase 1 clinical trial. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics AG in 2007. Nabriva Therapeutics AG was incorporated in 2005 and is headquartered in Vienna, Austria.
Digipath
NBRV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NBRV News: Antimicrobials Working Group Announces Updates to Leadership Team 10:00 AM
NBRV News: Nabriva Therapeutics Announces Webcast of Analyst & Investor Day on January 23, 2019 01/15/2019 07:00:00 AM
NBRV News: Current Report Filing (8-k) 01/14/2019 04:43:57 PM
NBRV News: Nabriva Therapeutics Provides Update on PDUFA Date for Intravenous CONTEPO™ 01/14/2019 07:00:00 AM
NBRV News: Current Report Filing (8-k) 01/04/2019 04:09:48 PM
News News Alert: Antimicrobials Working Group Announces Updates to Leadership Team 01/17/2019 10:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#97  Sticky Note NEWS PDUFA ACCELERATED TO APRIL 3OTH!!!! bUrRpPPP! 01/14/19 12:07:51 PM
#99   Nabriva Therapeutics Announces Webcast of Analyst & Investor bUrRpPPP! 01/15/19 07:24:18 AM
#98   Sooner is good. Also implies simpler which nsomniyak 01/14/19 06:29:59 PM
#97   NEWS PDUFA ACCELERATED TO APRIL 3OTH!!!! bUrRpPPP! 01/14/19 12:07:51 PM
#96   New Drug Application (NDA) from June 30, 2019 bUrRpPPP! 01/14/19 12:06:49 PM
#95   Here's the best part.......no hiccups..... bUrRpPPP! 01/04/19 07:51:59 AM
#94   U.S. Food and Drug Administration (FDA) has accepted realfast95 01/04/19 07:34:07 AM
#93   ty Message in reply to: [SMART MONEY] 12/28/18 09:46:18 AM
#92   May want to put NBRV back on your bUrRpPPP! 12/28/18 08:16:25 AM
#91   Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical realfast95 12/20/18 07:09:27 AM
#89   Is Lefamulin dead? It would explain why bUrRpPPP! 11/12/18 06:59:33 AM
#88   CONTEPO has been granted Qualified Infectious Disease Product bUrRpPPP! 11/01/18 07:57:21 AM
#87   NBRV $3.10 WEEEEEEEEEEE! bUrRpPPP! 10/04/18 06:16:15 AM
#86   Upgraded by Morgan Stanley today with $8pt. AngryMoose 09/07/18 08:38:43 AM
#85   NBRV chart bUrRpPPP! 09/07/18 08:12:35 AM
#84   ADVM realfast95 08/23/18 01:17:04 PM
#83   I think we'll be good. NDAs to AngryMoose 08/09/18 10:33:25 AM
#82   Q2 results out no surprises jumped in $2.35 bUrRpPPP! 08/09/18 07:22:01 AM
#81   Acquisition of Zavante killed any chance of a bUrRpPPP! 08/07/18 07:05:45 PM
#80   I think it's a good entry as well. AngryMoose 08/07/18 05:34:02 PM
#79   Nah. It will rally but it will AngryMoose 08/07/18 05:32:49 PM
#78   66,484,159 Ordinary Shares outstanding as of July 31, 2018 bUrRpPPP! 08/07/18 05:06:41 PM
#77   $2.35 What a complete disaster here. bUrRpPPP! 08/07/18 04:34:05 PM
#76   Nice ammount.. bought 477 at 2,50 lol but slopak 08/04/18 08:06:51 AM
#75   Bought 16k shares at 2.45. New long AngryMoose 07/27/18 05:16:24 PM
#74   Nabriva Therapeutics Prices Public Offering of 18.18M Ordinary realfast95 07/27/18 07:06:56 AM
#73   Great Top line late stage Lefamulin drug cash_cow1 06/04/18 03:46:00 PM
#72   Continuing large insiders buying being filed with the cash_cow1 06/04/18 02:30:20 PM
#71   Nabriva Therapeutics employees is now buying large shares cash_cow1 05/24/18 10:10:52 AM
#70   Nabriva "the company" believe strongly in its products. cash_cow1 05/24/18 09:58:45 AM
#69   Large insiders buying yesterday filed with the SEC. cash_cow1 05/24/18 09:52:10 AM
#68   gen sec insider buy realfast95 05/23/18 12:45:20 PM
#67   DJ Nabriva Therapeutics Price Target Raised to $11.00/Share realfast95 05/22/18 11:23:09 AM
#66   Brett Jensen tweet realfast95 05/22/18 08:41:03 AM
#65   Nabriva Falls On Lefamulin Safety Concerns, But Issues realfast95 05/22/18 06:45:16 AM
#64   Cantor Fitzgerald did the last stock offering, of Acen176 05/21/18 08:53:13 PM
#63   H.C. Wainwright Thinks Nabriva’s Stock is Going to Recover realfast95 05/21/18 07:49:06 PM
#62   https://www.markets.co/h-c-wainwright-thinks-nabrivas-stock-is-going-to-recover/ realfast95 05/21/18 07:06:49 PM
#61   I read more positive than negative [SMART MONEY] 05/21/18 06:36:42 PM
#60   Thanks...already sold half on a bounce to 4.95. girlfriend 05/21/18 12:14:40 PM
#59   you might get a bounce, but the big realfast95 05/21/18 12:13:14 PM
#58   https://www.cnbc.com/2018/05/21/reuters-america-update-3-nabriva-shares-tumble-a girlfriend 05/21/18 12:08:48 PM
#57   Overreaction? Are you buying? girlfriend 05/21/18 12:01:04 PM
#56   tweet BioWorld ? @BioWorld realfast95 05/21/18 11:57:48 AM
#55   Nbrv. Stools. 70% mild. 30% moderate. No drop randychub 05/21/18 11:49:43 AM
#54   tweet Bryan Green realfast95 05/21/18 11:48:25 AM
#53   Grabbed some 4.77's hope I want them. girlfriend 05/21/18 10:21:48 AM
#52   NBRV ma(50) 5.04 [SMART MONEY] 05/21/18 10:06:24 AM
#51   red 5.25 unreal [SMART MONEY] 05/21/18 09:57:29 AM
#50   Nice! > PT of $18 & $16. > crudeoil24 05/21/18 09:07:18 AM
#49   added 6.18's to my 6.29's [SMART MONEY] 05/21/18 09:04:18 AM
PostSubject